ePatient Insights - Clinical trial recruitment in the age of the ePatient

Описание: We now have the means to harness big data and to analyse and apply it to virtually any business sector, including the pharmaceutical industry. Yet big data is rarely used to inform clinical trial planning; either to select trial sites, set targets for patient recruitment or for subsequent recruitment efforts.

At least 90% of clinical trials are extended by six weeks or more from failure to enrol on time. As many as 50% of research sites enrol one patient, or none at all. And trial delays can seriously delay new treatments from reaching patients and cost the trial sponsor between $600,000 and $8 million per day in lost sales. So, ignoring the applications of big data is a missed opportunity.

Tudor Reilly Health's new report, "Clinical trial recruitment in the age of the ePatient", reveals -- through up-to-date case studies -- how online technology and detailed analysis of the data it produces can give trial sponsors startling new insights into where they should locate clinical trials to maximise patient recruitment.

The results often highlight major discrepancies between where clinical trial sites are planned or up-and-running and where prospective trial participants -- the epatients -- may actually live.